Dr. Michael Schulz currently serves as the Head of Legal & Corporate Development at Partex NV since April 2022. Before this role, Dr. Schulz was Senior Legal Counsel at Luther Corporate Services Sdn Bhd in Malaysia from October 2021 to April 2022. Prior experience includes positions as Counsel and Associate at BROICH Partnerschaft von Rechtsanwälten mbB from March 2015 to September 2021. Dr. Schulz holds a Doctor of Law degree from Goethe University Frankfurt and completed the Staatsexamen in Jurastudium at The Julius Maximilians University of Würzburg. Additional academic pursuits include studies at Università di Siena.
This person is not in any teams
This person is not in any offices
Partex
Partex NV is the first digital pharma platform that is set to be the largest AI-powered Drug Assets Manager. With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain. What sets us apart: - Within the Partex ecosystem, patients keep ownership of their data and they are rewarded for participating in research projects - Our AI/ML algorithms enable key industry players to develop life-saving drugs while also developing our own drug assets - A strong history of success and performance: from humble software beginnings to a fully-fledged platform with over 250 employees in 3 continents Our vision is to transform the Life science Industry by curing incurable diseases and increasing humanity's longevity. We dare to care! We have a global presence that extends from APAC to the Americas, with offices currently in India, Germany, Switzerland and USA. CEO & Co-Founder: Dr. Gunjan Bhardwaj Chairman & Co-Founder: Francisco Fernandez Companies belonging to Partex group: www.innoplexus.com www.cureteq.com www.perpetualblock.io www.amrit.ai www.assay.works